![](/img/cover-not-exists.png)
Metronomic scheduling of imatinib abrogates clonogenicity of neuroblastoma cells and enhances their susceptibility to selected chemotherapeutic drugs in vitro and in vivo
Ebba Palmberg, John Inge Johnsen, Janna Paulsson, Helena Gleissman, Malin Wickström, Margareta Edgren, Arne Östman, Per Kogner, Magnus LindskogVolume:
124
Year:
2009
Language:
english
Pages:
8
DOI:
10.1002/ijc.24069
File:
PDF, 267 KB
english, 2009